logo

For the Inventor, By the Inventor

Arendonk, Belgium

Leo J Backx

USPTO Granted Patents = 32

Average Co-Inventor Count = 3.0

ph-index = 12

Forward Citations = 410(Granted Patents)


Location History:

  • Geel, BE (1976)
  • Arendonk, BE (1979 - 1999)

Company Filing History:

goldMedal31 out of 2,079 
 
Janssen Pharmaceutica Nv
 patents
silverMedal1 out of 4 
 
Janssen Pharmacuetica N.v.
 patents

Years Active: 1976-1999

Loading Chart...
32 patents (USPTO):Explore Patents
1. 5929075 - Apolipoprotein-B synthesis inhibitors (1999-07-27),
2. 5922718 - Triazolones as apolipoprotein-B synthesis inhibitors (1999-07-13),
3. 5707977 - Watersoluble azole antifungals (1998-01-13),
4. 5521186 - Apolipoprotein-.beta. synthesis inhibitors (1996-05-28),
5. 5075309 - Antifungal (1991-12-24),
6. 4939162 - 1-(2-aryl-1,3-dioxon-2-ylmethyl)-1H-imidazoles and 1H-1,2,4-triazoles (1990-07-03),
7. 4931444 - 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols (1990-06-05),
8. 4916134 - 4-[4-[4-[4-[[2-(2,4-difluoro (1990-04-10),
9. 4861879 - [ (1989-08-29),
10. 4791111 - [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]- (1988-12-13),
11. 4735942 - [[4 (1988-04-05),
12. 4619931 - [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-diox (1986-10-28),
13. 4602010 - Fungicidal (1986-07-22),
14. 4598085 - Fungicidal 1-(2-aryl-2-R-ethyl)-1H-1,2,4-triazoles (1986-07-01),
15. 4524110 - Antimicrobial imidazole derivatives (1985-06-18),

Title: Leo J Backx: An Innovator Revolutionizing Pharmaceuticals

Introduction:

In the ever-evolving landscape of pharmaceutical sciences, Leo J Backx has emerged as a key player in developing groundbreaking solutions. Hailing from Arendonk, Belgium, this prolific inventor has made significant contributions to the field, holding an impressive portfolio of 32 patents. Working at the renowned Janssen Pharmaceutica Nv, Leo J Backx has been instrumental in advancing novel therapies and revolutionizing the industry.

Latest Patents:

Leo J Backx's latest patents include "Apolipoprotein-B synthesis inhibitors" and "Triazolones as apolipoprotein-B synthesis inhibitors." These patents highlight his expertise in tackling complex medical conditions by targeting apolipoprotein-B synthesis, a vital protein involved in lipid metabolism. Leo's innovative approach is paving the way for potential therapeutic interventions to combat various cardiovascular diseases.

Career Highlights:

Throughout his career, Leo J Backx has consistently pushed the boundaries of pharmaceutical research and development. The number of his patents, standing at an impressive 32, speaks volumes about his dedication and expertise in the field. His contributions have undoubtedly played a pivotal role in advancing medical science and improving patient outcomes.

Collaborations:

Collaboration often serves as a fertile ground for innovation, and Leo J Backx recognizes the value of working alongside like-minded individuals. In his professional journey, he has had the privilege of collaborating with fellow experts, Jan Heeres and Joseph H Mostmans. Through their combined efforts, they have successfully developed groundbreaking pharmaceutical solutions, setting new standards in the field.

Conclusion:

Leo J Backx is a highly respected innovator, known for his contributions to the pharmaceutical industry. With an impressive array of patents to his name, he continues to drive advancements that have the potential to transform patient care and improve quality of life. As Leo works alongside top professionals at Janssen Pharmaceutica Nv, his passion for invention and dedication to his craft enable the development of cutting-edge therapies that address critical medical needs. Through his continued efforts, Leo J Backx is shaping the future of pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…